• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Lazard Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    3/3/25 8:00:47 AM ET
    $LAZ
    Investment Managers
    Finance
    Get the next $LAZ alert in real time by email
    laz-20250303
    0001311370FALSE00013113702025-03-032025-03-03

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    ________________________________________________
    FORM 8-K
    ________________________________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): March 3, 2025
    ________________________________________________
    Lazard, Inc.
    (Exact name of registrant as specified in its charter)
    ________________________________________________
    Delaware001-3249298-0437848
    (State or Other Jurisdiction
    of Incorporation)
    (Commission File Number)(IRS Employer
    Identification No.)
    30 Rockefeller Plaza
    New York, New York
    10112
    (Address of Principal Executive Offices)(Zip Code)
    Registrant’s Telephone Number, Including Area Code: 212-632-6000
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)
    ________________________________________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading
    Symbol(s)
    Name of each exchange on which registered
    Common Stock, par value $0.01 per shareLAZNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
    Emerging growth company o
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
    Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On March 3, 2025, the Company announced that the Board of Directors (the “Board”) elected Peter Harrison to join the Board, effective immediately. Mr. Harrison will serve on the Audit and Workplace and Culture Committees of the Board. Mr. Harrison will receive compensation pursuant to the Company’s directors’ compensation program for independent directors of the Company, the terms of which are described in Item 1 of the Company’s Definitive Proxy Statement on Schedule 14A filed on March 21, 2024, and are incorporated herein by reference. A copy of the Company’s press release announcing the election of Mr. Harrison is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

    Item 7.01     Regulation FD Disclosure.

    A copy of the Company’s press release announcing the appointment described under Item 5.02 above is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

    The information in this Current Report on Form 8-K under Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.

    Item 9.01     Financial Statements and Exhibits.
    (d)Exhibits.
    Exhibit No.Description
    99.1
    Press Release issued March 3, 2025
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
    LAZARD, INC.
    (Registrant)
    By:/s/ Shari L. Soloway
    Name:Shari L. Soloway
    Title:Corporate Secretary
    Dated: March 3, 2025

    Get the next $LAZ alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LAZ

    DatePrice TargetRatingAnalyst
    4/7/2025$56.00 → $33.00Equal-Weight → Underweight
    Morgan Stanley
    1/3/2025Outperform → Peer Perform
    Wolfe Research
    12/20/2024$65.00 → $57.00Outperform → Mkt Perform
    Keefe Bruyette
    12/9/2024$60.00 → $63.00Overweight → Equal-Weight
    Morgan Stanley
    9/12/2024$51.00Equal Weight
    Wells Fargo
    1/29/2024$51.00Outperform
    Keefe Bruyette
    1/3/2024$42.00Peer Perform → Outperform
    Wolfe Research
    9/19/2023$37.00 → $32.00Neutral → Sell
    Goldman
    More analyst ratings